EffCaMgCit for Chronic Kidney Disease

Phase-Based Progress Estimates
DaVita Dialysis Centers, Dallas, TXChronic Kidney DiseaseEffCaMgCit - Drug
18 - 99
All Sexes
What conditions do you have?

Study Summary

This trial will explore whether effervescent calcium magnesium citrate (EffCaMgCit) can help people with end stage renal disease on hemodialysis by reducing the formation of calciprotein particles (CPP), which can cause heart and artery problems.

Eligible Conditions
  • Chronic Kidney Disease Stage 5

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 24 months

24 months
Control of hyperphosphatemia and serum FGF23
Intracellular muscle magnesium
Parathyroid function and bone turnover
Serum T50 for CPP

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

2 Treatment Groups

1 of 2
1 of 2

Active Control

Experimental Treatment

243 Total Participants · 2 Treatment Groups

Primary Treatment: EffCaMgCit · No Placebo Group · Phase 2 & 3

Experimental Group · 1 Intervention: EffCaMgCit · Intervention Types: Drug
ActiveComparator Group · 1 Intervention: CaAcS · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 24 months

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor
962 Previous Clinical Trials
1,108,144 Total Patients Enrolled
Henry Quinones, MDPrincipal InvestigatorUTSW

Eligibility Criteria

Age 18 - 99 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are there still opportunities to enroll in this research project?

"Yes, this study is still looking for participants and was most recently updated on February 9th, 2022. The original posting date was January 22nd, 2017." - Anonymous Online Contributor

Unverified Answer

Does this research only include young adults in their twenties?

"To be eligible for this particular trial, patients must be between 18-99 years old. However, there are other ongoing trials for patients that are under 18 and ones for patients that are over 65." - Anonymous Online Contributor

Unverified Answer

How many research subjects are involved in this trial?

"Yes, the trial is still recruiting patients according to the information on clinicaltrials.gov. This specific study was first posted on 1/22/2017 and was edited on 2/9/2022. The research team is looking for 225 individuals total from 1 site." - Anonymous Online Contributor

Unverified Answer

What are the requirements to sign up for this clinical trial?

"This study is currently enrolling 225 patients with chronic kidney disease. To be eligible, patients must be between 18 and 99 years old. In addition, the following criteria must be met: Adult subjects (> 21 years of age, any cause of CKD) of either gender of any ethnicity with CKD Stage V on hemodialysis will be recruited. Patients with Type II diabetes and hypertension will be allowed. Treatment with drugs for management of osteoporosis (bisphosphonate, teriparatide, or denosumab) or for chronic kidney disease, customary drugs for hypertension or diabetes, and exogenous estrogen or" - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.